Clavam 625 Tablet Prescription: Required MANUFACTURER: Alkem Laboratories Ltd SALT COMPOSITION: Amoxycillin (500mg) + Clavulanic Acid (125mg) STORAGE: Store below 30°CINTRODUCTION
Clavam 625 Tablet is a penicillin-type of antibiotic that helps your body fight infections caused by bacteria. It is used to treat infections of the lungs (e.g., pneumonia), ear, nasal sinus, urinary tract, skin, and soft tissue. It will not work for viral infections such as the common cold. Clavam 625 Tablet is best taken with a meal to reduce the chance of a stomach upset.BENEFITS OF CLAVAM TABLET
In Treatment of Bacterial infections Clavam 625 Tablet contains two different medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria. This combination medicine can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.SIDE EFFECTS OF CLAVAM TABLET
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them: Common side effects of Clavam - Vomiting - Nausea - DiarrheaHOW CLAVAM TABLET WORKS
Clavam 625 Tablet is a combination of two medicines: Amoxycillin and Clavulanic Acid. Amoxycillin is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Amoxycillin against bacteria.Fact Box
Habit Forming: No Therapeutic Class: ANTI INFECTIVES
Wednesday, December 8, 2021
Clavam 625
Labels:
Medicine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment